Work

Clinical Course, Management, and the Role of MEFV Mutations in PFAPA Syndrome: A Single-center Experience

Year: 2026
Type: article
Study design: Observational Study
Abstract: Objective: Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome is a periodic fever syndrome that onsets in early childhood.The precise roles of medical treatments in symptom control have not yet been clarified.This study aimed to evaluate the clinical characteristics, treatment responses, and genetic findings of children diagnosed with PFAPA.Method: Patients who were followed with a diagnosis of PFAPA between January 2021 and January 2025 were included in the study.Demographic data, clinical and laboratory findings, results of genetic analyses, and responses to corticosteroids, colchicine, and tonsillectomy were retrospectively evaluated.Results: A total of 22 patients with a mean age of 77.6 months (male cases: 50%) were included in the study.The median duration of attacks was 4 days [interquartile range (IQR): 3-6], and the median interval between attacks was 30 days (IQR: 25-41.3).Mediterranean fever (MEFV) gene mutations were detected in 36.4% (n=8) of the patients.All patients benefited from corticosteroid therapy during attacks; however, an increase in attack frequency was observed in 45.5% of cases.A decrease in attack frequency was observed in 57.1% (4/7) of the patients using colchicine.Tonsillectomy was performed in 63.6% (n=14) of the patients, and no postoperative complications were observed, while complete recovery was achieved in all cases.Conclusion: Our findings demonstrate that tonsillectomy is an effective treatment method for controlling febrile attacks in PFAPA.
Language: English
Open Access status: diamond
OpenAlex ID: W7203939733
FWCI:
Cites: 26
Cited by:
Related to: 10